Medlife, PharmEasy agree to merge; deal may be valued at over $1 bn

E-health companies Medlife and PharmEasy have agreed for a merger, according to the filings submitted by the companies to the Competition Commission of India (CCI). The proposed combination relates to the acquisition of 100 per cent equity shares of Medlife by API Holdings, the parent of PharmEasy, in return for 19.59 per cent equity share capital, according to the CCI filing. 
 

The deal values the stake of Medlife shareholders for about $200-$250 million, according to the sources. The aim is to create one of the largest healthcare companies and the valuation of the combined entity is expected to be over